Home
Storia in 2 fonti
Incyte signs AI deals with Genesis and Edison, tapping its experimental data
Delaware-based Incyte is now turning to AI to power through the coming decades.
- ·
forbes.com
Inside Incyte’s $120 Million AI For Drug Development Deal
In this week’s edition of InnovationRx, we look at a new AI drug development deal, a pill for sleep apnea, Commure’s $7 billion valuation, nd more.
- ·
endpoints.news
Incyte signs AI deals with Genesis and Edison, tapping its experimental data
Delaware-based Incyte is now turning to AI to power through the coming decades.